Nvidia-Backed Recursion Pharmaceuticals Stock Is Up On Q1 Earnings: Everything You Need To Know
and interest in Recursion’s data and technology solutions,” said Chris Gibson, co-founder and CEO of Recursion. “It is great ...
Nvidia-backed Recursion to acquire Exscientia in all-stock deal
Recursion (RXRX) will be the surviving entity led by co-founder and CEO Chris Gibson. Exscientia’s (EXAI) interim CEO David ...
Nasdaq7d
Recursion Rings the Opening Bell
Executives from Recursion (Nasdaq ... To mark the occasion, Co-Founder and CEO Chris Gibson, PhD, rings the opening bell and share the Company’s vision for the exciting future of TechBio ...
pharmaphorum1y
Bayer pledges up to $1.5bn for Recursion oncology alliance
scaled datasets and accelerated computing,” said Chris Gibson, co-founder and chief executive of Recursion. The Bayer alliance highlights “the scale and broad-scale applicability of our ...